Veterinary Vaccines Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Veterinary Vaccines Market to 2027 - Global Analysis and Forecasts by Vaccine Type (Livestock Vaccines, Companion Animal Vaccines); Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines) and Geography

Report Code: TIPRE00003539 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Vaccination have been proven to be an effective way of reducing disease burden in the pets and farm animals. It has also been a key tool in maintaining animal health and welfare. The vaccines continue to play a significant role in the development of safe, effective, and quality vaccines as well as acts a preventive health measure among animals. Effective vaccinations are available for multitude of diseases in the animals, although the complex nature of vaccine production can lead to technical difficulties in its development.

MARKET DYNAMICS
The veterinary vaccines market is anticipated to grow in the forecast, owing to the factors such as increasing globalization leading to outbreak of several animal diseases, technological developments in vaccines, and increasing demand for animal protection therapeutics. In addition, initiatives undertaken by various government and non-government organizations for animal health care & protection is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Veterinary Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of veterinary vaccines market with detailed market segmentation by vaccine type, technology, and geography. The global veterinary vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading veterinary vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global veterinary vaccines market is segmented on the basis of vaccine type, technology, and geography. Based on vaccine type, the market is segmented as livestock vaccines and companion animal vaccines. On the basis of technology, the global veterinary vaccines market is segmented into, live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global veterinary vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The veterinary vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting veterinary vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the veterinary vaccines market in these regions.

MARKET PLAYERS
The reports cover key developments in the veterinary vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from veterinary vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for veterinary vaccines market in the global market. Below mentioned is the list of few companies engaged in the veterinary vaccines market.
The report also includes the profiles of key veterinary vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Boehringer Ingelheim GmbH
  • Merck KGaA
  • Zoetis Inc.
  • Eli Lilly and Company
  • Bayer AG
  • Ceva
  • Virbac
  • NEOGEN CORPORATION
  • Biovac
  • ImmuCell Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Veterinary Vaccines Market - By Vaccine Type
1.3.2 Veterinary Vaccines Market - By Technology
1.3.3 Veterinary Vaccines Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. VETERINARY VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VETERINARY VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VETERINARY VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. VETERINARY VACCINES - GLOBAL MARKET OVERVIEW
6.2. VETERINARY VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VETERINARY VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TYPE
7.1. OVERVIEW
7.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
7.3. LIVESTOCK VACCINES
7.3.1. Overview
7.3.2. Livestock Vaccines Market Forecast and Analysis
7.3.3. Bovine Vaccines Market
7.3.3.1. Overview
7.3.3.2. Bovine Vaccines Market Forecast and Analysis
7.3.4. Poultry Vaccines Market
7.3.4.1. Overview
7.3.4.2. Poultry Vaccines Market Forecast and Analysis
7.3.5. Porcine Vaccines Market
7.3.5.1. Overview
7.3.5.2. Porcine Vaccines Market Forecast and Analysis
7.3.6. Others Market
7.3.6.1. Overview
7.3.6.2. Others Market Forecast and Analysis
7.4. COMPANION ANIMAL VACCINES
7.4.1. Overview
7.4.2. Companion Animal Vaccines Market Forecast and Analysis
7.4.3. Canine Vaccines Market
7.4.3.1. Overview
7.4.3.2. Canine Vaccines Market Forecast and Analysis
7.4.4. Feline Vaccines Market
7.4.4.1. Overview
7.4.4.2. Feline Vaccines Market Forecast and Analysis
7.4.5. Equine Vaccines Market
7.4.5.1. Overview
7.4.5.2. Equine Vaccines Market Forecast and Analysis
8. VETERINARY VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. LIVE ATTENUATED VACCINES
8.3.1. Overview
8.3.2. Live Attenuated Vaccines Market Forecast and Analysis
8.4. INACTIVATED VACCINES
8.4.1. Overview
8.4.2. Inactivated Vaccines Market Forecast and Analysis
8.5. TOXOID VACCINES
8.5.1. Overview
8.5.2. Toxoid Vaccines Market Forecast and Analysis
8.6. RECOMBINANT VACCINES
8.6.1. Overview
8.6.2. Recombinant Vaccines Market Forecast and Analysis
8.7. CONJUGATE VACCINES
8.7.1. Overview
8.7.2. Conjugate Vaccines Market Forecast and Analysis
9. VETERINARY VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Veterinary Vaccines Market Overview
9.1.2 North America Veterinary Vaccines Market Forecasts and Analysis
9.1.3 North America Veterinary Vaccines Market Forecasts and Analysis - By Vaccine Type
9.1.4 North America Veterinary Vaccines Market Forecasts and Analysis - By Technology
9.1.5 North America Veterinary Vaccines Market Forecasts and Analysis - By Countries
9.1.5.1 United States Veterinary Vaccines Market
9.1.5.1.1 United States Veterinary Vaccines Market by Vaccine Type
9.1.5.1.2 United States Veterinary Vaccines Market by Technology
9.1.5.2 Canada Veterinary Vaccines Market
9.1.5.2.1 Canada Veterinary Vaccines Market by Vaccine Type
9.1.5.2.2 Canada Veterinary Vaccines Market by Technology
9.1.5.3 Mexico Veterinary Vaccines Market
9.1.5.3.1 Mexico Veterinary Vaccines Market by Vaccine Type
9.1.5.3.2 Mexico Veterinary Vaccines Market by Technology
9.2. EUROPE
9.2.1 Europe Veterinary Vaccines Market Overview
9.2.2 Europe Veterinary Vaccines Market Forecasts and Analysis
9.2.3 Europe Veterinary Vaccines Market Forecasts and Analysis - By Vaccine Type
9.2.4 Europe Veterinary Vaccines Market Forecasts and Analysis - By Technology
9.2.5 Europe Veterinary Vaccines Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Veterinary Vaccines Market
9.2.5.1.1 Germany Veterinary Vaccines Market by Vaccine Type
9.2.5.1.2 Germany Veterinary Vaccines Market by Technology
9.2.5.2 France Veterinary Vaccines Market
9.2.5.2.1 France Veterinary Vaccines Market by Vaccine Type
9.2.5.2.2 France Veterinary Vaccines Market by Technology
9.2.5.3 Italy Veterinary Vaccines Market
9.2.5.3.1 Italy Veterinary Vaccines Market by Vaccine Type
9.2.5.3.2 Italy Veterinary Vaccines Market by Technology
9.2.5.4 Spain Veterinary Vaccines Market
9.2.5.4.1 Spain Veterinary Vaccines Market by Vaccine Type
9.2.5.4.2 Spain Veterinary Vaccines Market by Technology
9.2.5.5 United Kingdom Veterinary Vaccines Market
9.2.5.5.1 United Kingdom Veterinary Vaccines Market by Vaccine Type
9.2.5.5.2 United Kingdom Veterinary Vaccines Market by Technology
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Veterinary Vaccines Market Overview
9.3.2 Asia-Pacific Veterinary Vaccines Market Forecasts and Analysis
9.3.3 Asia-Pacific Veterinary Vaccines Market Forecasts and Analysis - By Vaccine Type
9.3.4 Asia-Pacific Veterinary Vaccines Market Forecasts and Analysis - By Technology
9.3.5 Asia-Pacific Veterinary Vaccines Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Veterinary Vaccines Market
9.3.5.1.1 Australia Veterinary Vaccines Market by Vaccine Type
9.3.5.1.2 Australia Veterinary Vaccines Market by Technology
9.3.5.2 China Veterinary Vaccines Market
9.3.5.2.1 China Veterinary Vaccines Market by Vaccine Type
9.3.5.2.2 China Veterinary Vaccines Market by Technology
9.3.5.3 India Veterinary Vaccines Market
9.3.5.3.1 India Veterinary Vaccines Market by Vaccine Type
9.3.5.3.2 India Veterinary Vaccines Market by Technology
9.3.5.4 Japan Veterinary Vaccines Market
9.3.5.4.1 Japan Veterinary Vaccines Market by Vaccine Type
9.3.5.4.2 Japan Veterinary Vaccines Market by Technology
9.3.5.5 South Korea Veterinary Vaccines Market
9.3.5.5.1 South Korea Veterinary Vaccines Market by Vaccine Type
9.3.5.5.2 South Korea Veterinary Vaccines Market by Technology
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Veterinary Vaccines Market Overview
9.4.2 Middle East and Africa Veterinary Vaccines Market Forecasts and Analysis
9.4.3 Middle East and Africa Veterinary Vaccines Market Forecasts and Analysis - By Vaccine Type
9.4.4 Middle East and Africa Veterinary Vaccines Market Forecasts and Analysis - By Technology
9.4.5 Middle East and Africa Veterinary Vaccines Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Veterinary Vaccines Market
9.4.5.1.1 South Africa Veterinary Vaccines Market by Vaccine Type
9.4.5.1.2 South Africa Veterinary Vaccines Market by Technology
9.4.5.2 Saudi Arabia Veterinary Vaccines Market
9.4.5.2.1 Saudi Arabia Veterinary Vaccines Market by Vaccine Type
9.4.5.2.2 Saudi Arabia Veterinary Vaccines Market by Technology
9.4.5.3 U.A.E Veterinary Vaccines Market
9.4.5.3.1 U.A.E Veterinary Vaccines Market by Vaccine Type
9.4.5.3.2 U.A.E Veterinary Vaccines Market by Technology
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Veterinary Vaccines Market Overview
9.5.2 South and Central America Veterinary Vaccines Market Forecasts and Analysis
9.5.3 South and Central America Veterinary Vaccines Market Forecasts and Analysis - By Vaccine Type
9.5.4 South and Central America Veterinary Vaccines Market Forecasts and Analysis - By Technology
9.5.5 South and Central America Veterinary Vaccines Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Veterinary Vaccines Market
9.5.5.1.1 Brazil Veterinary Vaccines Market by Vaccine Type
9.5.5.1.2 Brazil Veterinary Vaccines Market by Technology
9.5.5.2 Argentina Veterinary Vaccines Market
9.5.5.2.1 Argentina Veterinary Vaccines Market by Vaccine Type
9.5.5.2.2 Argentina Veterinary Vaccines Market by Technology
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. VETERINARY VACCINES MARKET, KEY COMPANY PROFILES
11.1. BOEHRINGER INGELHEIM GMBH
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MERCK KGAA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ZOETIS INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ELI LILLY AND COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BAYER AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CEVA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. VIRBAC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NEOGEN CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BIOVAC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. IMMUCELL CORPORATION
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Boehringer Ingelheim GmbH
2. Merck KGaA
3. Zoetis Inc.
4. Eli Lilly and Company
5. Bayer AG
6. Ceva
7. Virbac
8. NEOGEN CORPORATION
9. Biovac
10. ImmuCell Corporation